1. Home
  2. CHRS vs ASST Comparison

CHRS vs ASST Comparison

Compare CHRS & ASST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRS
  • ASST
  • Stock Information
  • Founded
  • CHRS 2010
  • ASST 2020
  • Country
  • CHRS United States
  • ASST United States
  • Employees
  • CHRS N/A
  • ASST N/A
  • Industry
  • CHRS Biotechnology: Biological Products (No Diagnostic Substances)
  • ASST Computer Software: Prepackaged Software
  • Sector
  • CHRS Health Care
  • ASST Technology
  • Exchange
  • CHRS Nasdaq
  • ASST Nasdaq
  • Market Cap
  • CHRS 84.2M
  • ASST 90.8M
  • IPO Year
  • CHRS 2014
  • ASST 2023
  • Fundamental
  • Price
  • CHRS $0.76
  • ASST $3.74
  • Analyst Decision
  • CHRS Buy
  • ASST
  • Analyst Count
  • CHRS 3
  • ASST 0
  • Target Price
  • CHRS $4.68
  • ASST N/A
  • AVG Volume (30 Days)
  • CHRS 1.3M
  • ASST 2.8M
  • Earning Date
  • CHRS 08-07-2025
  • ASST 08-13-2025
  • Dividend Yield
  • CHRS N/A
  • ASST N/A
  • EPS Growth
  • CHRS N/A
  • ASST N/A
  • EPS
  • CHRS N/A
  • ASST N/A
  • Revenue
  • CHRS $272,251,000.00
  • ASST $679,397.00
  • Revenue This Year
  • CHRS N/A
  • ASST N/A
  • Revenue Next Year
  • CHRS $106.56
  • ASST N/A
  • P/E Ratio
  • CHRS N/A
  • ASST N/A
  • Revenue Growth
  • CHRS 19.87
  • ASST 99.39
  • 52 Week Low
  • CHRS $0.66
  • ASST $0.34
  • 52 Week High
  • CHRS $2.43
  • ASST $13.42
  • Technical
  • Relative Strength Index (RSI)
  • CHRS 46.35
  • ASST 38.32
  • Support Level
  • CHRS $0.72
  • ASST $4.56
  • Resistance Level
  • CHRS $0.77
  • ASST $5.27
  • Average True Range (ATR)
  • CHRS 0.04
  • ASST 0.57
  • MACD
  • CHRS 0.00
  • ASST -0.32
  • Stochastic Oscillator
  • CHRS 38.69
  • ASST 3.85

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.

About ASST Asset Entities Inc. Class B

Asset Entities Inc is an Internet company providing social media marketing, content delivery, and development and design services across Discord, TikTok, and other social media platforms. The company has developed three categories of services, which include: providing subscription upgrades to premium content on investment education and entertainment servers on Discord; co-developing and executing influencer social media and marketing campaigns for clients; and designing, developing, and managing Discord servers for clients under AE.360.DDM brand. In addition, it offers Ternary v2, a cloud-based subscription management and payment processing solution for Discord communities, which includes a suite of customer relations management tools and Stripe-verified payment processing.

Share on Social Networks: